Jim Mellon is a British entrepreneur, investor, and philanthropist with a wide range of interests. Through his private investment company, Burnbrae Group, he has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies. Jim’s investment philosophy is underpinned by careful analysis of new industries or major shifts in markets. This includes the global financial crisis of 2008-2009, as foreseen in the first book Jim co-authored entitled Wake Up!, and subsequently in the book Juvenescence which marked the beginning of a rush of capital into the nascent field of aging research and also led to the formation of the company Juvenescence with his partners. Juvenescence is a leading biopharma company in the commercialization of therapies to slow, stop and reverse aging. More recently Jim authored the book Moo’s Law, focused on investment opportunities in the field of cellular agriculture - the production of proteins and materials directly from cells. Jim co-founded Agronomics to invest in a portfolio of leading companies in this sector and is its largest investor. Jim sits on the Board of Trustees of the Buck Institute for Research on Aging, and of the American Federation for Aging Research (AFAR). He is also a trustee of Biogerontology Research Foundation and is an Honorary Fellow of Oriel College at the University of Oxford, where he has established the Mellon Centre for Longevity, and Jim also sits on the Advisory Board of the Milken Institute’s Centre for the Future of Aging.